Testing effectiveness (Phase 2)Study completedNCT01527188
What this trial is testing
Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber Model
Who this might be right for
Allergic Rhinitis Due to House Dust Mite
Stallergenes Greer 355